Related Experiment Video
Updated: Jul 12, 2026

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Role of macrophages in complications of type 2 diabetes
1Department of Nephrology and Monash University Department of Medicine, Monash Medical Centre, Clayton, Victoria, Australia. greg.tesch@med.monash.edu.au
Abstract:
1. Macrophage accumulation is a feature of Type 2 diabetes and is associated with the development of diabetic complications (nephropathy, atherosclerosis, neuropathy and retinopathy). The present article reviews the current evidence that macrophages contribute to the complications of Type 2 diabetes. 2. Macrophage-depletion studies in rodent models have demonstrated a causal role for macrophages in the development of diabetic complications. 3. Components of the diabetic milieu (high glucose, advanced glycation end-products and oxidized low-density lipoprotein) promote macrophage accumulation (via induction of chemokines and adhesion molecules) and macrophage activation within diabetic tissues. 4. Macrophages mediate diabetic injury through a variety of mechanisms, including production of reactive oxygen species, cytokines and proteases, which result in tissue damage leading to sclerosis. 5. A number of existing and experimental therapies can indirectly reduce macrophage-mediated injury in diabetic complications. The present article discusses the use of these therapies, given alone and in combination, in suppressing macrophage accumulation and activity. 6. In conclusion, current evidence supports a critical role for macrophages in the evolution of diabetic complications. Present therapies are limited in slowing the progression of macrophage-mediated injury. Novel strategies that are more specific at targeting macrophages may provide better protection against the development of Type 2 diabetic complications.
Insights
Macrophages drive Type 2 diabetes complications like nephropathy and retinopathy. Depletion studies confirm their causal role, and novel therapies targeting these cells are needed for better protection.
Area of Science:
- Immunology
- Endocrinology
- Pathology
Background:
- Macrophage accumulation is a hallmark of Type 2 diabetes.
- This accumulation is linked to diabetic complications including nephropathy, atherosclerosis, neuropathy, and retinopathy.
Purpose of the Study:
- To review evidence on macrophage contribution to Type 2 diabetes complications.
- To discuss current and experimental therapies targeting macrophage-mediated injury.
Main Methods:
- Review of current scientific literature.
- Analysis of macrophage-depletion studies in rodent models.
- Examination of mechanisms by which macrophages mediate diabetic injury.
Main Results:
- Macrophage depletion in rodent models confirms their causal role in diabetic complications.
- Diabetic conditions (high glucose, AGEs, oxLDL) promote macrophage accumulation and activation.
- Macrophages cause tissue damage via ROS, cytokines, and proteases.
Conclusions:
- Macrophages play a critical role in the development of Type 2 diabetic complications.
- Current therapies offer limited success in slowing macrophage-mediated injury.
- Targeting macrophages specifically may offer improved protection against diabetic complications.
Related Concept Videos
Complications of Diabetes Mellitus
Type II Diabetes II: Pathophysiology
Type I Diabetes II: Pathophysiology
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications

